Armata Pharmaceuticals (ARMP)

• Market cap: $326M
• 1 day: -10.92%
• 5 days: -29.28%
• 1 month: -15.81%
• 3 months: 14.86%
• 6 months: 84.06%
• Year to date: 35.52%
• 1 year: 558.52%
• 5 years: 116.83%
• 10 years: -97.9%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Employees: 61